Investigating the less than sterling economic performance of the biotechnology sector over the course of the past three decades, Pisano (business administration, Harvard Business School) argues that the industry is not structurally organized to handle the technologically- dictated functional requirements of risk management, integration, and learning. He argues that this is because a strong focus on monetizing intellectual property has impeded flows of information, led to fragmentation, and created a proliferation of new firms, all of which work against the previously named functional requirements. If biotech is to overcome this situation, it needs to realize that it can't just borrow business models, organizational strategies, and approaches from other high technology industries and must fashion a business strategy that is specifically tailored to the scientific requirements of biotech. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)